期刊
ANNALS OF THE RHEUMATIC DISEASES
卷 64, 期 2, 页码 176-178出版社
B M J PUBLISHING GROUP
DOI: 10.1136/ard.2003.018556
关键词
-
类别
The first choice for prevention of corticosteroid osteoporosis is a potent oral bisphosphonate-for example, alendronate or risedronate. Intravenous bisphosphonates should be considered for patients intolerant of the oral route. For patients receiving chronic low dose corticosteroids treatment with calcium and vitamin D may prevent further bone loss. Use of parathyroid hormone is promising.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据